Published in Postepy Dermatol Alergol on June 20, 2013
Patchy alopecia areata sparing gray hairs: a case series. Postepy Dermatol Alergol (2014) 0.75
Glaucoma from topical corticosteroids to the eyelids. Clin Experiment Ophthalmol (2004) 2.03
Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol (2012) 1.77
Tacrolimus: the drug for the turn of the millennium? Arch Dermatol (1999) 1.69
0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial. Br J Dermatol (2004) 1.53
Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol (2002) 1.23
Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics (2002) 1.22
Effects of 1-year intermittent treatment with topical tacrolimus monotherapy on skin collagen synthesis in patients with atopic dermatitis. Br J Dermatol (2004) 1.08
Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants. J Pediatr (2003) 1.08
Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus. Int J Pharm (2004) 1.07
Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. Arch Dermatol (2001) 0.98
The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review. Br J Dermatol (2007) 0.95
Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies. J Am Acad Dermatol (2005) 0.95
Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Dermatology (2005) 0.93
Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis. Dermatology (2004) 0.93
Value-based medicine, comparative effectiveness, and cost-effectiveness analysis of topical cyclosporine for the treatment of dry eye syndrome. Arch Ophthalmol (2009) 0.92
Proactive therapy of atopic dermatitis--an emerging concept. Allergy (2008) 0.89
Tacrolimus: a review of its use for the management of dermatoses. J Eur Acad Dermatol Venereol (2002) 0.88
Binding of pimecrolimus and tacrolimus to skin and plasma proteins: implications for systemic exposure after topical application. Drug Metab Dispos (2008) 0.87
Onset of pruritus relief with pimecrolimus cream 1% in adult patients with atopic dermatitis: a randomized trial. Allergy (2006) 0.85
Pimecrolimus in dermatology: atopic dermatitis and beyond. Int J Clin Pract (2005) 0.84
Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison. J Am Acad Dermatol (2005) 0.84
The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis. Am J Clin Dermatol (2007) 0.84
Clinical controversy on the effect of topical ciclosporin: what is the target site? Dermatology (1992) 0.83
Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. Acta Derm Venereol (2007) 0.82
Long-term efficacy and tolerability of tacrolimus 0.03% ointment in infants:* a two-year open-label study. Int J Dermatol (2011) 0.82
A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients. Br J Dermatol (2008) 0.82
Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis. Br J Dermatol (2008) 0.80
Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children. Arch Dis Child (2006) 0.79
[Topical cyclosporine in the treatment of oral pemphigus]. Minerva Stomatol (1998) 0.77
Systemic absorption of topical tacrolimus in Pyoderma gangrenosum. Acta Derm Venereol (2006) 0.77
Significant systemic absorption of tacrolimus after topical application in a patient with lamellar ichthyosis. Arch Dermatol (2002) 0.77
[Age-related macular degeneration (AMD): etiopathogenesis and therapeutic strategies]. Postepy Hig Med Dosw (Online) (2007) 0.91
Efficacy and safety of the Betamethasone valerate 0.1% plaster in mild-to-moderate chronic plaque psoriasis: a randomized, parallel-group, active-controlled, phase III study. Am J Clin Dermatol (2011) 0.91
The use of spa and phage typing for characterization of clinical isolates of methicillin-resistant Staphylococcus aureus in the University Clinical Center in Gdańsk, Poland. Folia Microbiol (Praha) (2012) 0.81
Efficacy and safety of the freeze-dried cultured human keratinocyte lysate, LyphoDerm 0.9%, in the treatment of hard-to-heal venous leg ulcers. Wound Repair Regen (2005) 0.81
[Age-related macular degeneration--a complex genetic disease]. Klin Oczna (2008) 0.81
Systemic contact dermatitis to nickel present in cocoa in 14-year-old boy. Pediatr Dermatol (2011) 0.80
In psoriasis, levels of hope and quality of life are linked. Arch Dermatol Res (2014) 0.79
A 10% glycolic acid containing oil-in-water emulsion improves mild acne: a randomized double-blind placebo-controlled trial. J Cosmet Dermatol (2011) 0.75
The potential of use basil and rosemary essential oils as effective antibacterial agents. Molecules (2013) 0.75
Effect of HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) reductase inhibitors on the concentration of insulin-like growth factor-1 (IGF-1) in hypercholesterolemic patients. Pharmacol Rep (2009) 0.75
Efficacy of Tofacitinib for the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis in Patient Subgroups from Two Randomised Phase 3 Trials. J Drugs Dermatol (2016) 0.75
[Factors forming opnion on marijuana legalization in Poland among group of students from medical and technical college faculty]. Przegl Lek (2015) 0.75